1887

Abstract

The IE2p86 protein of human cytomegalovirus is an essential activator of early- and late-phase viral gene expression. Whilst IE2p86 activates expression of a number of cellular genes, it also represses certain cellular genes, particularly those activated by nuclear factor B (NF-B). As the interleukin-6 () promoter can be activated by both NF-B and IE2p86, it was examined whether there is competition between these two factors. Here, it is reported that both wild-type and mutant IE2p86 can block activation of the promoter in response to interleukin-1. By using an artificial activator in which the activation domain of NF-B is directed to the promoter by the GAL4 DNA-binding domain, it is shown that the mutant form of IE2p86 can inhibit NF-B-mediated activation at a step subsequent to promoter recruitment. These data therefore suggest a novel mechanism for inhibition of NF-B by IE2p86.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82925-0
2007-09-01
2019-12-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/9/2435.html?itemId=/content/journal/jgv/10.1099/vir.0.82925-0&mimeType=html&fmt=ahah

References

  1. Barrasa, M. I., Harel, N., Yu, Y. & Alwine, J. C. ( 2003; ). Strain variations in single amino acids of the 86-kilodalton human cytomegalovirus major immediate-early protein (IE2) affect its functional and biochemical properties: implications of dynamic protein conformation. J Virol 77, 4760–4772.[CrossRef]
    [Google Scholar]
  2. Bryant, L. A., Mixon, P., Davidson, M., Bannister, A. J., Kouzarides, T. & Sinclair, J. H. ( 2000; ). The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF. J Virol 74, 7230–7237.[CrossRef]
    [Google Scholar]
  3. Buss, H., Dorrie, A., Schmitz, M. L., Hoffmann, E., Resch, K. & Kracht, M. ( 2004; ). Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKϵ, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279, 55633–55643.[CrossRef]
    [Google Scholar]
  4. Caswell, R., Hagemeier, C., Chiou, C. J., Hayward, G., Kouzarides, T. & Sinclair, J. ( 1993; ). The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol 74, 2691–2698.[CrossRef]
    [Google Scholar]
  5. Chen, L. F. & Greene, W. C. ( 2004; ). Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 5, 392–401.[CrossRef]
    [Google Scholar]
  6. Gealy, C., Denson, M., Humphreys, C., McSharry, B., Wilkinson, G. & Caswell, R. ( 2005; ). Post-transcriptional suppression of interleukin-6 production by human cytomegalovirus. J Virol 79, 472–485.[CrossRef]
    [Google Scholar]
  7. Hagemeier, C., Walker, S., Caswell, R., Kouzarides, T. & Sinclair, J. ( 1992; ). The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J Virol 66, 4452–4456.
    [Google Scholar]
  8. Hofmann, H., Floss, S. & Stamminger, T. ( 2000; ). Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol 74, 2510–2524.[CrossRef]
    [Google Scholar]
  9. Jupp, R., Hoffmann, S., Stenberg, R. M., Nelson, J. A. & Ghazal, P. ( 1993; ). Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol 67, 7539–7546.
    [Google Scholar]
  10. Lukac, D. M., Harel, N. Y., Tanese, N. & Alwine, J. C. ( 1997; ). TAF-like functions of human cytomegalovirus immediate-early proteins. J Virol 71, 7227–7239.
    [Google Scholar]
  11. Mocarski, E. S., Jr & Courcelle, C. T. ( 2001; ). Cytomegaloviruses and their replication. In Fields Virology, 4th edn, pp. 2629–2673. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
  12. Pizzorno, M. C., Mullen, M. A., Chang, Y. N. & Hayward, G. S. ( 1991; ). The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J Virol 65, 3839–3852.
    [Google Scholar]
  13. Schwartz, R., Helmich, B. & Spector, D. H. ( 1996; ). CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol 70, 6955–6966.
    [Google Scholar]
  14. Shimizu, H., Mitomo, K., Watanabe, T., Okamoto, S. & Yamamoto, K. ( 1990; ). Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 10, 561–568.
    [Google Scholar]
  15. Sommer, M. H., Scully, A. L. & Spector, D. H. ( 1994; ). Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol 68, 6223–6231.
    [Google Scholar]
  16. Song, Y.-J. & Stinski, M. F. ( 2002; ). Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc Natl Acad Sci U S A 99, 2836–2841.[CrossRef]
    [Google Scholar]
  17. Taylor, R. T. & Bresnahan, W. A. ( 2005; ). Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J Virol 79, 3873–3877.[CrossRef]
    [Google Scholar]
  18. Taylor, R. T. & Bresnahan, W. A. ( 2006a; ). Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFκB-dependent gene expression. J Virol 80, 10763–10771.[CrossRef]
    [Google Scholar]
  19. Taylor, R. T. & Bresnahan, W. A. ( 2006b; ). Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 80, 920–928.[CrossRef]
    [Google Scholar]
  20. Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M. L., Fiers, W. & Haegeman, G. ( 1998; ). p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273, 3285–3290.[CrossRef]
    [Google Scholar]
  21. Walker, S., Hagemeier, C., Sissons, J. G. & Sinclair, J. H. ( 1992; ). A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80- kilodalton IE2 protein. J Virol 66, 1543–1550.
    [Google Scholar]
  22. Yamit-Hezi, A. & Dikstein, R. ( 1998; ). TAFII105 mediates activation of anti-apoptotic genes by NF-κB. EMBO J 17, 5161–5169.[CrossRef]
    [Google Scholar]
  23. Yeung, K. C., Stoltzfus, C. M. & Stinski, M. F. ( 1993; ). Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter. Virology 195, 786–792.[CrossRef]
    [Google Scholar]
  24. Zhang, Y. H., Lin, J. X. & Vilcek, J. ( 1990; ). Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a κB-like sequence. Mol Cell Biol 10, 3818–3823.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82925-0
Loading
/content/journal/jgv/10.1099/vir.0.82925-0
Loading

Data & Media loading...

Supplements

vol. , part 9, pp. 2435 – 2440

Binding of IE2p86 and CAD291 to basal transcription factors

Sequence of the human IL-6 promoter

[ Single PDF file] (36 KB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error